(Q53342780)

13 May 2018

title

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. (English)

1 reference

13 May 2018

author

Richard O. Day

9

1 reference

13 May 2018

Paul Emery

2

object named as

Emery P

1 reference

13 May 2018

13

Kvien TK

1 reference

13 May 2018

Brooks P

1

1 reference

13 May 2018

Evans JF

3

1 reference

13 May 2018

Fenner H

4

1 reference

13 May 2018

Hawkey CJ

5

1 reference

13 May 2018

Patrono C

6

1 reference

13 May 2018

Smolen J

7

1 reference

13 May 2018

Breedveld F

8

1 reference

13 May 2018

Dougados M

10

1 reference

13 May 2018

Ehrich EW

11

1 reference

13 May 2018

Gijon-Baños J

12

1 reference

13 May 2018

Van Rijswijk MH

14

1 reference

13 May 2018

Warner T

15

1 reference

13 May 2018

Zeidler H

16

1 reference

13 May 2018

publication date

1 August 1999

1 reference

13 May 2018

published in

Rheumatology

1 reference

13 May 2018

volume

38

1 reference

13 May 2018

issue

8

1 reference

13 May 2018

page(s)

779-788

1 reference

13 May 2018

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Prostaglandin endoperoxide synthase: structure and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Peripheral analgesia: mechanism of the analgesic action of aspirin-like drugs and opiate-antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroid mild analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Structure of the human cyclo-oxygenase-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Prostaglandin endoperoxide synthase: regulation of enzyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

New insights into the mode of action of anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear str

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Nonsteroidal anti-inflammatory drugs: effects on kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Review article: COX-II inhibitors--a new generation of safer NSAIDs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Effects of nabumetone on prostanoid biosynthesis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

The clinical implications of inhibition of the inducible form of cyclo-oxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F38.8.779

10.1093/RHEUMATOLOGY/38.8.779

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

Dimensions Publication ID

0 references

1 reference

13 May 2018